N/A
N=214
Symptom-Based Markers for COVID-19 Transmission
Covid19
Bottom Line
View on ClinicalTrials.gov: NCT04665245 ↗Enrolled (actual)
214
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: Body Temperature — 98.1 degrees Fahrenheit
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Iowa
- Primary completion
- May 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Body Temperature |
98.1 | — |
| PRIMARY COVID-19 Symptoms |
956; 1532; 1669; 305; 141; 1140 | — |
Summary
In this study, COVID-19 positive patients will be added to a bidirectional texting program to receive daily surveys about their symptoms with the infection. This data will further the understanding of COVID-19 symptom development throughout the infection period, as well as how those symptoms vary at different points of the day. This study will be a single cohort, observational study of COVID-19 patients.
Eligibility Criteria
Inclusion Criteria
- Fluent in English
- Tested positive for COVID-19
Exclusion Criteria
- Prisoners
- Unable to provide own informed consent
Data sourced from ClinicalTrials.gov (NCT04665245). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.